Lv51
820 积分 2022-05-11 加入
Regorafenib enhances anti-PDCD1/PD-1 therapeutic efficacy in colorectal cancer by promoting SQSTM1/p62-mediated CD274/PD-L1 degradation
7天前
已完结
An RNA vaccine drives expansion and efficacy of claudin-CAR-T cells against solid tumors
12天前
已完结
Mechanisms underlying resistance to CAR-T cell therapy and strategies for enhancement
15天前
已完结
The immune microenvironment of colorectal cancer
20天前
已完结
Oncogenic KRAS drives immunosuppression of colorectal cancer by impairing DDX60-mediated dsRNA accumulation and viral mimicry
21天前
已完结
Repeated peripheral infusions of anti-EGFRvIII CAR T cells in combination with pembrolizumab show no efficacy in glioblastoma: a phase 1 trial
27天前
已完结
Clinical Pharmacology Characterization of Bispecific T‐Cell Engagers: A Summary Based on FDA Approvals
1个月前
已完结
Characterization of anti-CD3 antibodies in clinically available bispecific T cell engagers
1个月前
已完结
Masking T cell engagers mitigates on-target off-tumor activity
1个月前
已完结
Engineering scFv immunotherapies: From CAR T cells to bispecific antibodies
1个月前
已完结
皖公网安备34019202002308